Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Control Intervention1: Group 1: patients will recieve 0.25% bupivacaine after skin closure
and efficacy of drug is assessed till 24hours after surgery
Control Intervention2: Group 2: patients will rec
Sponsors
Department of anaesthesiology
Eligibility
Inclusion criteria
Inclusion criteria: All patients of ASA grade I and grade II patients between 18 to 65yrs
Exclusion criteria
Exclusion criteria: 1]patient refusal to the procedure 2]any contraindications for regional anaesthesia technique like infection at the site of injection 3]coagulation disorder 4]drug allergy 5]history of other cancer 6]history of previous breast surgery 7]ASA grade IV 8]respiratory disease, cardiac disease and renal disease 9]having chemotherapy or radiotherapy in recent 8 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| comparing the efficacy of 0.25% bupivacaine and 0.25% levobupivacaine in Carcinoma breast surgeries using PEC 2 block and the duration of postoperative analgesiaTimepoint: 24 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| total rescue analgesia required in the first 24hrsTimepoint: 24hrs | — |
Countries
India
Contacts
Public ContactDR DEEPA KATTISHETTAR
Mysore medical college and research institute
Outcome results
None listed